Edgar Lomax Company’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $40.7M | Buy |
1,449,272
+856,970
| +145% | +$22.8M | 2.9% | 13 |
|
|
2025
Q4 | $14.7M | Sell |
592,302
-17,705
| -3% | -$446K | 1.12% | 40 |
|
|
2025
Q3 | $15.5M | Sell |
610,007
-182,473
| -23% | -$4.5M | 1.22% | 34 |
|
|
2025
Q2 | $19.2M | Sell |
792,480
-12,920
| -2% | -$301K | 1.22% | 35 |
|
|
2025
Q1 | $20.4M | Sell |
805,400
-628,910
| -44% | -$16.5M | 1.28% | 35 |
|
|
2024
Q4 | $38.1M | Sell |
1,434,310
-34,490
| -2% | -$936K | 2.45% | 16 |
|
|
2024
Q3 | $42.5M | Sell |
1,468,800
-23,325
| -2% | -$680K | 2.59% | 14 |
|
|
2024
Q2 | $41.7M | Sell |
1,492,125
-18,990
| -1% | -$523K | 2.71% | 12 |
|
|
2024
Q1 | $41.9M | Buy |
1,511,115
+562,791
| +59% | +$15.6M | 2.59% | 13 |
|
|
2023
Q4 | $27.3M | Sell |
948,324
-43,329
| -4% | -$1.31M | 1.78% | 26 |
|
|
2023
Q3 | $32.9M | Sell |
991,653
-17,952
| -2% | -$635K | 2.24% | 19 |
|
|
2023
Q2 | $37M | Sell |
1,009,605
-13,955
| -1% | -$543K | 2.44% | 18 |
|
|
2023
Q1 | $41.8M | Sell |
1,023,560
-52,060
| -5% | -$2.25M | 2.69% | 15 |
|
|
2022
Q4 | $55.1M | Sell |
1,075,620
-6,275
| -0.6% | -$301K | 3.34% | 11 |
|
|
2022
Q3 | $47.3M | Buy |
1,081,895
+330,040
| +44% | +$16M | 3.27% | 11 |
|
|
2022
Q2 | $39.4M | Buy |
751,855
+20,900
| +3% | +$1.07M | 2.47% | 15 |
|
|
2022
Q1 | $37.8M | Sell |
730,955
-34,760
| -5% | -$1.8M | 2.22% | 17 |
|
|
2021
Q4 | $45.2M | Sell |
765,715
-7,365
| -1% | -$365K | 2.71% | 13 |
|
|
2021
Q3 | $33.3M | Sell |
773,080
-15,460
| -2% | -$685K | 2.13% | 18 |
|
|
2021
Q2 | $30.9M | Sell |
788,540
-13,065
| -2% | -$508K | 1.92% | 22 |
|
|
2021
Q1 | $29M | Sell |
801,605
-1,013,555
| -56% | -$36M | 1.81% | 23 |
|
|
2020
Q4 | $66.8M | Sell |
1,815,160
-133,804
| -7% | -$4.91M | 4.54% | 5 |
|
|
2020
Q3 | $67.9M | Buy |
1,948,964
+75,150
| +4% | +$2.63M | 5.23% | 2 |
|
|
2020
Q2 | $58.1M | Buy |
1,873,814
+36,808
| +2% | +$1.25M | 4.65% | 3 |
|
|
2020
Q1 | $56.9M | Buy |
1,837,006
+332,458
| +22% | +$11.3M | 5.05% | 4 |
|
|
2019
Q4 | $55.9M | Sell |
1,504,548
-27,928
| -2% | -$995K | 3.6% | 6 |
|
|
2019
Q3 | $52.2M | Sell |
1,532,476
-16,759
| -1% | -$609K | 3.49% | 8 |
|
|
2019
Q2 | $63.7M | Sell |
1,549,235
-23,820
| -2% | -$946K | 4.33% | 5 |
|
|
2019
Q1 | $63.4M | Sell |
1,573,055
-82,765
| -5% | -$3.31M | 4.35% | 5 |
|
|
2018
Q4 | $68.6M | Sell |
1,655,820
-25,797
| -2% | -$1.07M | 5.21% | 2 |
|
|
2018
Q3 | $70.3M | Sell |
1,681,617
-60,326
| -3% | -$2.32M | 4.72% | 4 |
|
|
2018
Q2 | $60M | Buy |
1,741,943
+12,332
| +0.7% | +$421K | 4.21% | 5 |
|
|
2018
Q1 | $58.2M | Buy |
1,729,611
+350,762
| +25% | +$12.1M | 4.19% | 5 |
|
|
2017
Q4 | $47.4M | Sell |
1,378,849
-42,255
| -3% | -$1.44M | 3.24% | 11 |
|
|
2017
Q3 | $48.1M | Sell |
1,421,104
-125,547
| -8% | -$4.04M | 3.4% | 9 |
|
|
2017
Q2 | $49.3M | Sell |
1,546,651
-41,001
| -3% | -$1.29M | 3.37% | 10 |
|
|
2017
Q1 | $51.5M | Sell |
1,587,652
-230,978
| -13% | -$7.28M | 3.45% | 9 |
|
|
2016
Q4 | $56M | Sell |
1,818,630
-159,707
| -8% | -$4.88M | 3.59% | 9 |
|
|
2016
Q3 | $63.6M | Sell |
1,978,337
-875
| -0% | -$29.3K | 3.94% | 8 |
|
|
2016
Q2 | $66.1M | Buy |
1,979,212
+98,965
| +5% | +$3.16M | 4.15% | 8 |
|
|
2016
Q1 | $52.9M | Buy |
1,880,247
+7,441
| +0.4% | +$213K | 3.63% | 10 |
|
|
2015
Q4 | $57.4M | Buy |
1,872,806
+41,949
| +2% | +$1.32M | 4.21% | 7 |
|
|
2015
Q3 | $54.6M | Sell |
1,830,857
-65,137
| -3% | -$2.09M | 4.14% | 5 |
|
|
2015
Q2 | $60.3M | Sell |
1,895,994
-24,269
| -1% | -$791K | 4.05% | 5 |
|
|
2015
Q1 | $63.4M | Sell |
1,920,263
-596,037
| -24% | -$18.9M | 4.14% | 5 |
|
|
2014
Q4 | $74.4M | Buy |
2,516,300
+267,738
| +12% | +$7.68M | 4.65% | 3 |
|
|
2014
Q3 | $63.1M | Buy |
2,248,562
+63,295
| +3% | +$1.78M | 4.28% | 5 |
|
|
2014
Q2 | $61.5M | Buy |
2,185,267
+7,536
| +0.3% | +$215K | 4.35% | 5 |
|
|
2014
Q1 | $66.4M | Buy |
2,177,731
+568,317
| +35% | +$16.9M | 4.9% | 3 |
|
|
2013
Q4 | $46.8M | Buy |
1,609,414
+276,043
| +21% | +$8.03M | 3.54% | 7 |
|
|
2013
Q3 | $36.3M | Sell |
1,333,371
-123,912
| -9% | -$3.37M | 2.98% | 9 |
|
|
2013
Q2 | $38.7M | Buy |
+1,457,283
| New | +$40.3M | 3.01% | 8 |
|
Other funds holding PFE
VCM
VPM
Edgar Lomax Company's PFE Position: Q1 2026 in Review
Edgar Lomax Company increased its Pfizer (PFE) stake by 145% in Q1 2026, buying an estimated $22.8M and bringing the position to 1,449,272 shares worth $40.7M. The position accounts for 2.9% of the portfolio, ranked #13.
Edgar Lomax Company first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $74.4M in Q4 2014. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Edgar Lomax Company held 1,449,272 shares of Pfizer worth $40.7M as of Q1 2026.
- Edgar Lomax Company bought 856,970 Pfizer shares in Q1 2026, an estimated $22.8M.
- Pfizer made up 2.9% of Edgar Lomax Company's portfolio in Q1 2026, its #13 holding.
- Edgar Lomax Company first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Edgar Lomax Company's Pfizer position peaked at $74.4M in Q4 2014.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Edgar Lomax Company's 13F filing for Q1 2026, filed 12 May 2026.